Skip to Main Content

Paper Details

Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA<sup>+</sup> individuals without a systemic autoimmune rheumatic disease diagnosis.
Arthritis Res Ther
3
2023
ANA, CXCL-10, Galectin-, Galectin-9, IFN, IFN-, IFNs, Interferon, SARD, SARDs, blood, interferon, interferons, patients, serum IFN, systemic autoimmune rheumatic disease, systemic autoimmune rheumatic diseases
Author NameAffiliation
Carolina Mu??oz-GrajalesSchroeder Arthritis Institute, Krembil Research Institute, University Health Network
Carolina Mu??oz-GrajalesUniversity of Toronto
Sindhu R JohnsonUniversity of Toronto
Sindhu R JohnsonToronto Western and Mount Sinai Hospitals
Zahi ToumaUniversity of Toronto
Zahi ToumaUniversity of Toronto Lupus Clinic, Schroeder Arthritis Institute, University Health Network
Zareen AhmadUniversity of Toronto
Zareen AhmadToronto Western and Mount Sinai Hospitals
Dennisse BonillaSchroeder Arthritis Institute, Krembil Research Institute, University Health Network
Linda T HirakiThe Hospital for Sick Children, University of Toronto
Arthur BookmanUniversity of Toronto
Arthur BookmanSchroeder Arthritis Institute, University Health Network
Joan E WitherSchroeder Arthritis Institute, Krembil Research Institute, University Health Network
Joan E WitherUniversity of Toronto
Joan E WitherUniversity of Toronto
Joan E WitherSchroeder Arthritis Institute, University Health Network
Joan E WitherSchroeder Arthritis Institute, Krembil Research Institute, University Health Network
Joan E WitherUniversity of Toronto
Joan E WitherUniversity of Toronto
Joan E WitherSchroeder Arthritis Institute, University Health Network
  • 1 - 20

Datasets